RecruitingNCT07118280
Oral Health, Saliva Viscosity and Composition in Oculo-Pharyngeal Muscular Dystrophy (OPMD)
Studying Oculopharyngeal muscular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sheba Medical Center
- Enrollment
- 100 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2027
Study locations (1)
- Sheba Medical Center, Ramat Gan, Israel
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07118280 on ClinicalTrials.govOther trials for Oculopharyngeal muscular dystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT06185673A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With DysphagiaBenitec Biopharma, Inc.
- RECRUITINGNCT07146256Natural History of Oculo-Pharyngeal Muscular Dystrophy (OPMD) - Israel National OPMD RegistrySheba Medical Center